Rosmarinic acid as a potential GSK3β inhibitor for autism spectrum disorder: insights from an integrative in silico study
Fields of Study & Subjects
Autism Spectrum Disorder Research
Transgenic Plants and Applications
Genetics and Neurodevelopmental Disorders
Publication details
- Journal / source
- In Silico Pharmacology
- Volume
- 14
- Issue
- 2
- Pages
- 124–124
- Publication date
- 28 April 2026
- Language
- EN